Biotech investing basics part 1: value in biotech

Рет қаралды 23,733

Күн бұрын

This is the first in a series of videos about how to invest in biotech. This video covers the concept of value in biotech and investing more generally. We look at Netflix and Seres Therapeutics as real-world examples.
If there are topics related to biotech investing you'd like for us to cover, or companies you'd like us to look at, let us know in the comments below!

Пікірлер: 36

@marcdean4064 2 жыл бұрын

I've been interested in entrepreneurship and biotechnology for a couple years but I've had no idea where to start, your channel and website have been a great diving board. I'm looking forward to learning more from Bay Bridge Bio, thank you and please keep up with your mission!

@KennyOcampo98 14 күн бұрын

💯💯💯

@BeyondBorders00 Жыл бұрын

Great introduction. Looking forward to the additional videos

@thaohuynh2984 2 жыл бұрын

Thank you so much for your content! It’s really helpful and I really hope you could keep posting on educational materials on biotech investing!

@santidiazvalenzuela232 Жыл бұрын

Excellent video with useful tips. You got a new subscriber!

@omkarbhatavdekar3757 2 жыл бұрын

Very solid series! Hope to see more videos :)

@joey_bag_a_donuts Жыл бұрын

genomic stocks are going to be some of the highest valued companies in the future. picking the best ones isn't really that hard when you start to read all the quarterly earnings and public statements. these stocks are weathered and beaten now. it's a good time to start dollar cost averaging those companies now. it's gonna take years, but it is a good long term investment in my opinion.

@joakimrantanen3401 Жыл бұрын

Thank you for this video! Extremely helpful information about the topic.

@katerinatema230 Жыл бұрын

Thank you for this video. Great tips in a simplified language for a beginner like me! I learned a lot

@ElizaRose641 2 жыл бұрын

Great content! Thank you!

@redditfm4578 2 жыл бұрын

Your channel is golden

@mikeechegaray7157 Жыл бұрын

Your content is awesome plainly simple

@ShdwftheSuN Жыл бұрын

Maybe I'm crazy but I'm starting my "investment journey" with biotech, so thank you for this invaluable information! Gonna start by buying some index and mutual funds for stability, and I will be primarily buying and trading with my dividends. Betting on my scientific literacy while getting my Public Health degree to judge which companies are worth it versus the hype. Wish me luck.

@subdiplomatic 7 ай бұрын

Biotech is the black tar heroine of the stock market. You're still going at it?

@ShdwftheSuN 7 ай бұрын

@@subdiplomatic My choice of pharmaceuticals is doing quite well! But I've been a bit too scared to enter the "tech" part honestly lol

@biovester 2 ай бұрын

@@ShdwftheSuN Genuinely curious in learning about your journey into biotech investing! Would you wanna chat sometime?

@krishnahira5061 11 ай бұрын

Great content. Would love to see you cover Argenx

@moko79 10 ай бұрын

great series. I was alarmed, when you mentioned Seres. At first I thought, you are going to talk about Syros (where I am invested in). But I am not english native speaker so I just got it wrong. However I would appreciate your 2 cents regarding Syros Pharmaceuticals (Flagship Pioneering is Co-Founder here).

@youngchung1858 2 жыл бұрын

thanks for the info, do you analyze @CELZ? will it run again next week?

@maddavisdog07 Жыл бұрын

Please look at CYT. They have company presentation with a nice slide show. You can break it Down as an example of how we can evaluate it

@adityasantoki6152 2 жыл бұрын

Would love to hear more about how you guys predict clinical trial results from preclinical data! In other words, is predicting clinical trial results pretty random or does the data available provide a good indicator of how well the drug candidate will do in trials?

@baybridgebio2576 2 жыл бұрын

Thanks for the input! Definitely a topic we will cover in the future.

@snowxu9214 2 жыл бұрын

yes, i agree as I would also love to hear more about predicting clinical trial results as sometimes the design of clinical trials will also related to the whether the trial will successful in the future! By the way, this is an amazing video, especially good company does not mean good investment

@alexandereisen3486 Жыл бұрын

So if you've done your research and you believe a biotech company has potential but they're in the beginning of clinical trials etc. Would a good strategy be to buy and hold small amounts of stock and let it ride out the volatility which is probably inevitable. As the drug looks more promising and continues to pass through phase 1-3 trials, you can start investing more and more money into the company?

@josephbeaulieu5210 2 жыл бұрын

Can you review SAVA from Cassava sciences?

@afrokid122 2 жыл бұрын

I would like to know more about this

@willlagergaming8089 8 ай бұрын

this video prevent degen from turning into serial killer.

@jake3028 2 жыл бұрын

ATAI 💪🏻

@piecesofme8531 Жыл бұрын

How do you investigate if there was a stock split or reverse stock split? That affects stock price without affecting company valuation.

@joey_bag_a_donuts Жыл бұрын

google the ticker symbol and "reverse split" you'll get the dates of any splits and reverse splits that have happened. steer clear of reverse splits. trust me.

@henrylopez00hl Жыл бұрын

Btai, thrx are currently what Im looking at

@austinchaney3041 Жыл бұрын

ATAI and Compass Pathways

@carterfinance2376 2 жыл бұрын

Are there any books that you would suggest reading for an investor to learn more about bio tech investing

@baybridgebio2576 2 жыл бұрын

I like the book Genentech: the beginnings of biotech by Sally Smith Hughes. Quick read and the playbook Genentech developed is still probably the best for building lasting biotechs. Also the associated interviews w the Genentech team are great and are available online at Berkeley Bancroft library Frank David (of Pharmagellan) has some good books on valuation and analyzing clinical data Other good books as well but I think the best way is to learn by doing, invest (only what you can afford to lose) and if you can, find a mentor with some experience to discuss ideas

@carterfinance2376 2 жыл бұрын

@@baybridgebio2576 Thank you so much I recently just bought genetech, the billion dollar molecular,The Pharmagellan Guide to Analyzing Biotech Clinical Trials and The Biotech Trader Handbook (2nd Edition). I have been very involved in banking the last 2 years and I wanted to potential research and invest in biotech. Your videos open my eyes to analyzing a clinical study and then seeing if the data is cherry picked or valid. Just wanted to thank you again.